Insider Trading & Ownership - Kelemen Vicki

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kelemen Vicki
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-23
Purchase
2021-03-23
2:30 pm
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
960$10.31$9,8986,053
(Direct)
View
2020-11-23
Sale
2020-11-25
4:02 pm
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
35,321$18.6$657,02075,695
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-03-15
Option Award
2023-03-16
5:41 pm
N/A
2033-03-15
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
125,520$0698,304
(Direct)
View
2022-03-09
Option Award
2022-03-10
6:40 pm
N/A
2032-03-09
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
170,016$0572,784
(Direct)
View
2021-06-10
Option Award
2021-06-14
4:12 pm
N/A
2031-06-10
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
200,928$0402,768
(Direct)
View
2021-01-02
Exercise
2021-01-05
4:04 pm
N/A
N/A
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
70$05,093
(Direct)
View
2021-01-02
Tax Withholding
2021-01-05
4:04 pm
N/A
N/A
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
31$05,093
(Direct)
View
2020-11-23
Exercise
2020-11-25
4:02 pm
N/A
2029-06-20
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
35,321$2.4875,695
(Direct)
View

Ownership
2020-06-22
7:36 pm
N/A
N/A
Cardiff Oncology Inc.CRDFKelemen Vicki
Exec. VP and COO
0$0242,285
(Direct)
View